ArticleOncoscience2018

Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.

Clarissa N Amaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.